ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Doxorubicin Accord liposomal 50 mg/25 ml, Konzentrat zur Herstellung einer Infusionsdispersion - 
68961002 Accord Healthcare AG
Doxorubicin Accord liposomal 50 mg/25 ml, Konzentrat zur Herstellung einer Infusionsdispersion09.01.2025
  09.01.2025
Doxorubicin (L01DB01) 
WHO-DDD08.01.2030
 
07.16.10. 
A  
No 
  
PR  
k.A.PR
  
7680689610023Synthetika
  
Composition
doxorubicini hydrochloridum 50 mg, phosphatidylcholinum ex soja hydrogenatum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, cholesterolum, histidinum, saccharum, acidum hydrochloridum concentratum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile, q.s. ad suspensionem pro 25 ml corresp. natrium max. 0.7975 mg.
Packungsbestandteile
 
Source
Data was imported : 07.02.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home